Eikon Therapeutics Stock Price, News & Analysis
Company Description
Eikon Therapeutics (NASDAQ: EIKN) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $597.1M, ranking #3,283 among all listed U.S. companies by market cap.
EIKN stock has declined 26.2% over the past year. Shares last traded at $11.07.
This page provides a comprehensive overview of EIKN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Eikon Therapeutics (EIKN) stock last traded at $11.07, down 0.45% from the previous close. Over the past 12 months, the stock has lost 26.2%. At a market capitalization of $597.1M, EIKN is classified as a small-cap stock with approximately 54.0M shares outstanding.
Latest News
Eikon Therapeutics has 1 recent news article. Key topics include IPO, offering. View all EIKN news →
SEC Filings
Eikon Therapeutics has filed 5 recent SEC filings, including 5 Form 4. The most recent filing was submitted on March 4, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all EIKN SEC filings →
Insider Radar
Insider buying activity at Eikon Therapeutics over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
EIKN Company Profile & Sector Positioning
Eikon Therapeutics (EIKN) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.